1. Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials. Issue 10326 (19th February 2022) Authors: Heier, Jeffrey S; Khanani, Arshad M; Quezada Ruiz, Carlos; Basu, Karen; Ferrone, Philip J; Brittain, Christopher; Figueroa, Marta S; Lin, Hugh; Holz, Frank G; Patel, Vaibhavi; Lai, Timothy Y Y; Silverman, David; Regillo, Carl; Swaminathan, Balakumar; Viola, Francesco; Cheung, Chui Ming Gemmy; Won... Journal: Lancet Issue: Volume 399:Issue 10326(2022) Page Start: 729 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials. Issue 10326 (19th February 2022) Authors: Wykoff, Charles C; Abreu, Francis; Adamis, Anthony P; Basu, Karen; Eichenbaum, David A; Haskova, Zdenka; Lin, Hugh; Loewenstein, Anat; Mohan, Shaun; Pearce, Ian A; Sakamoto, Taiji; Schlottmann, Patricio G; Silverman, David; Sun, Jennifer K; Wells, John A; Willis, Jeffrey R; Tadayoni, Ramin; Aaber... Journal: Lancet Issue: Volume 399:Issue 10326(2022) Page Start: 741 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. IMPACT OF RETINAL FLUID-FREE MONTHS ON OUTCOMES IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Treatment Agnostic Analysis of the HAWK and HARRIER Studies. Issue 4 (28th April 2023) Authors: Eichenbaum, David; Brown, David M.; Ip, Michael; Khanani, Arshad M.; Figueroa, Marta S.; McAllister, Ian L.; Laude, Augustinus; B, Guruprasad; Tang, Shuhan; Gmeiner, Benjamin; Clemens, Andreas; Souied, Eric Journal: Retina Issue: Volume 43:Issue 4(2023) Page Start: 632 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OPTIMAL MANAGEMENT OF PIGMENT EPITHELIAL DETACHMENTS IN EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Issue 11 (November 2018) Authors: Khanani, Arshad M.; Eichenbaum, David; Schlottmann, Patricio G.; Tuomi, Lisa; Sarraf, David Journal: Retina Issue: Volume 38:Issue 11(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Ranibizumab and Neovascular Age-related Macular Degeneration. Issue 2 (2021) Authors: Chen, Xuejing; Eichenbaum, David; Baumal, Caroline R Journal: Touch reviews in ophthalmology Issue: Volume 15:Issue 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Two-year interim safety results of the 0.2 µg/day fluocinolone acetonide intravitreal implant for the treatment of diabetic macular oedema: the observational PALADIN study. Issue 3 (27th May 2020) Authors: Mansour, Sam E; Kiernan, Daniel F; Roth, Daniel B; Eichenbaum, David; Holekamp, Nancy M; Kaba, Samer; Werts, Erica Journal: British journal of ophthalmology Issue: Volume 105:Issue 3(2021) Page Start: 414 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗